Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction

• Michele Pohlen ,

  Contributed equally to this work with: Michele Pohlen, Nils H. Thoennissen

  * E-mail: michele.pohlen@ukmuenster.de

  Affiliation Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• Nils H. Thoennissen ,

  Contributed equally to this work with: Michele Pohlen, Nils H. Thoennissen

  Current address: Hospital of Kloster Paradiese, Soest-Paradiese, Germany

  Affiliation Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• Jan Braess,

  Current address: Department of Oncology and Hematology, Hospital Barmherzigen Brueder, Regensburg, Germany

  Affiliation Department of Medicine III, Hematology and Oncology, University Hospital Grosshadern, Munich, Germany

  ⨯
• Johannes Thudium,

  Affiliation Department of Medicine III, Hematology and Oncology, University Hospital Grosshadern, Munich, Germany

  ⨯
• Christoph Schmid,

  Affiliation Department of Medicine II, Klinikum Augsburg, Augsburg, Germany

  ⨯
• Matthias Kochanek,

  Affiliation Department of Medicine I, University Hospital Cologne, Cologne, Germany

  ⨯
• Karl-Anton Kreuzer,

  Affiliation Department of Medicine I, University Hospital Cologne, Cologne, Germany

  ⨯
• Pia Lebiedz,

  Affiliation Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany

  ⨯
• Dennis Görlich,

  Affiliation Institute of Biostatistics and Clinical Research, University Muenster, Muenster, Germany

  ⨯
• Hans U. Gerth,

  Affiliation Department of Medicine D, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• Christian Rohde,

  Current address: Department of Medicine IV, University Hospital Halle-Wittenberg, Halle/Saale, Germany

  Affiliation Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• Torsten Kessler,

  Affiliation Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• Carsten Müller-Tidow,

  Current address: Department of Medicine IV, University Hospital Halle-Wittenberg, Halle/Saale, Germany

  Affiliation Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• Matthias Stelljes,

  Affiliation Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• Thomas Büchner,

  Affiliation Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• Günter Schlimok,

  Affiliation Department of Medicine II, Klinikum Augsburg, Augsburg, Germany

  ⨯
• Michael Hallek,

  Affiliation Department of Medicine I, University Hospital Cologne, Cologne, Germany

  ⨯
• Johannes Waltenberger,

  Affiliation Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany

  ⨯
• Wolfgang Hiddemann,

  Affiliation Department of Medicine III, Hematology and Oncology, University Hospital Grosshadern, Munich, Germany

  ⨯
• Wolfgang E. Berdel ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• Bernhard Heilmeier ,

  Current address: Department of Oncology and Hematology, Hospital Barmherzigen Brueder, Regensburg, Germany

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Medicine II, Klinikum Augsburg, Augsburg, Germany

  ⨯
•  [ ... ],
• Utz Krug

  Current address: Department of Medicine 3, Klinikum Leverkusen, Leverkusen, Germany

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany

  ⨯
• [ view all ]
• [ view less ]